【摘要】 本文旨在明确我国医药制造业合作创新资金投入受到哪些因素影响及其作用机制，为提升我国医药制造业合作创新资金投入水平提供参考。基于2000—2019年我国医药制造业相关指标数据，使用因子分析方法实证分析所归纳因素对医药制造业合作创新资金投入的影响。研发资金内部投入、科技活动人员投入、二次创新、技术引进、新产品开发投入、企业规模、吸收能力、新产品盈利水平、新产品出口贸易、盈利水平、专利申请、有效发明专利、政府资助和产业集中度均正向激励我国整体医药制造业合作创新资金投入；而企业开放度与我国整体医药制造业合作创新资金投入之间则是负相关关系。更多还原

【Abstract】 The aim of the article was to clarify the factors affecting the investment in cooperative innovation in China’s pharmaceutical manufacturing industry and its mechanism of action, thus to provide reference for improving the level of investment. Based on the relevant index data of China’s pharmaceutical manufacturing industry from 2000 to 2019, the factor analysis method was used to empirically analyze the influencing factors on the investment in cooperative innovation in the pharmaceutical manufacturing industry. It was found that internal investment of research and development funds, investment in scientific and technological activities, secondary innovation, technology introduction, investment in new product development, enterprise scale, absorption capacity, new product profitability, new product export trade, profitability, patent applications, effective invention patents, government funding, and industry concentration were positive incentives for cooperative innovation capital investment in China’s overall pharmaceutical manufacturing industry, while the enterprise openness had a negative impact.更多还原